# Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity

> **NCT07018622** · PHASE2 · RECRUITING · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 46 (estimated)

## Conditions studied

- Solid Tumors
- Cisplatin Nephrotoxicity

## Interventions

- **DRUG:** Dapagliflozin 10 MG Oral Tablet
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT07018622
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-07
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-10-30
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07018622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07018622, "Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07018622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*